
Leah H. Schlientz
Examiner (ID: 11673, Phone: (571)272-9928 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 788 |
| Issued Applications | 280 |
| Pending Applications | 127 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16175593
[patent_doc_number] => 20200222561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => Ultrasound Gel Composition
[patent_app_type] => utility
[patent_app_number] => 16/834871
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834871
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/834871 | Ultrasound Gel Composition | Mar 29, 2020 | Abandoned |
Array
(
[id] => 16178192
[patent_doc_number] => 20200225160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => METHODS AND SYSTEMS FOR SPATIALLY IDENTIFYING ABNORMAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/829498
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16829498
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/829498 | Methods and systems for spatially identifying abnormal cells | Mar 24, 2020 | Issued |
Array
(
[id] => 16153507
[patent_doc_number] => 20200214986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS
[patent_app_type] => utility
[patent_app_number] => 16/823058
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823058 | Rapidly disintegrating gelatinous coated tablets | Mar 17, 2020 | Issued |
Array
(
[id] => 16153507
[patent_doc_number] => 20200214986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS
[patent_app_type] => utility
[patent_app_number] => 16/823058
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823058 | Rapidly disintegrating gelatinous coated tablets | Mar 17, 2020 | Issued |
Array
(
[id] => 16304196
[patent_doc_number] => 10772967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Enhanced anticancer agent
[patent_app_type] => utility
[patent_app_number] => 16/784971
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 35
[patent_no_of_words] => 25383
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 388
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784971
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/784971 | Enhanced anticancer agent | Feb 6, 2020 | Issued |
Array
(
[id] => 16204947
[patent_doc_number] => 20200237937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => COMPOSITIONS AND METHODS FOR ASSESSING MACROPHAGE MEDIATED PATHOLOGY
[patent_app_type] => utility
[patent_app_number] => 16/773512
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773512
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773512 | COMPOSITIONS AND METHODS FOR ASSESSING MACROPHAGE MEDIATED PATHOLOGY | Jan 26, 2020 | Abandoned |
Array
(
[id] => 16252231
[patent_doc_number] => 20200261605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => FUNCTIONALIZED LIPOSOMES FOR IMAGING MISFOLDED PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/751943
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 380
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751943
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751943 | FUNCTIONALIZED LIPOSOMES FOR IMAGING MISFOLDED PROTEINS | Jan 23, 2020 | Abandoned |
Array
(
[id] => 15863157
[patent_doc_number] => 20200138982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE
[patent_app_type] => utility
[patent_app_number] => 16/730029
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16730029
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/730029 | RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE | Dec 29, 2019 | Abandoned |
Array
(
[id] => 17426951
[patent_doc_number] => 20220054659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => PSMA-TARGETED PAMAM DENDRIMERS FOR SPECIFIC DELIVERY OF IMAGING, CONTRAST AND THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/312548
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312548
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312548 | PSMA-TARGETED PAMAM DENDRIMERS FOR SPECIFIC DELIVERY OF IMAGING, CONTRAST AND THERAPEUTIC AGENTS | Dec 12, 2019 | Pending |
Array
(
[id] => 17385572
[patent_doc_number] => 20220033424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => FLUOROUS METAL CHELATES COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/311299
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -75
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/311299 | Fluorous metal chelates compositions | Dec 8, 2019 | Issued |
Array
(
[id] => 17503563
[patent_doc_number] => 20220096665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => BIMODAL NANOPARTICLE CONJUGATES FOR NON-INVASIVE CENTRAL NERVOUS SYSTEM TISSUE IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/296129
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296129 | BIMODAL NANOPARTICLE CONJUGATES FOR NON-INVASIVE CENTRAL NERVOUS SYSTEM TISSUE IMAGING | Nov 19, 2019 | Pending |
Array
(
[id] => 17503563
[patent_doc_number] => 20220096665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => BIMODAL NANOPARTICLE CONJUGATES FOR NON-INVASIVE CENTRAL NERVOUS SYSTEM TISSUE IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/296129
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296129 | BIMODAL NANOPARTICLE CONJUGATES FOR NON-INVASIVE CENTRAL NERVOUS SYSTEM TISSUE IMAGING | Nov 19, 2019 | Pending |
Array
(
[id] => 16451114
[patent_doc_number] => 20200360540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION
[patent_app_type] => utility
[patent_app_number] => 16/688540
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16688540
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/688540 | FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION | Nov 18, 2019 | Abandoned |
Array
(
[id] => 17342230
[patent_doc_number] => 20220008561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => BISMUTH METAL-ORGANIC FRAMEWORKS FOR USE AS X-RAY COMPUTED TOMOGRAPHY CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/293176
[patent_app_country] => US
[patent_app_date] => 2019-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293176
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293176 | BISMUTH METAL-ORGANIC FRAMEWORKS FOR USE AS X-RAY COMPUTED TOMOGRAPHY CONTRAST AGENTS | Nov 12, 2019 | Abandoned |
Array
(
[id] => 17235506
[patent_doc_number] => 11179369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Sustained release pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 16/672296
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11184
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16672296
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/672296 | Sustained release pharmaceutical compositions | Oct 31, 2019 | Issued |
Array
(
[id] => 15863167
[patent_doc_number] => 20200138987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => COMPOSITION FOR MATERIAL DELIVERY, INCLUDING EXOSOME MIMETICS DERIVED FROM RED BLOOD CELLS, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/670044
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16670044
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/670044 | Composition for material delivery, including exosome mimetics derived from red blood cells, and use thereof | Oct 30, 2019 | Issued |
Array
(
[id] => 15524933
[patent_doc_number] => 20200054772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => Nanoparticle Photoacoustic Imaging Agents
[patent_app_type] => utility
[patent_app_number] => 16/661067
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16661067
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/661067 | Nanoparticle Photoacoustic Imaging Agents | Oct 22, 2019 | Abandoned |
Array
(
[id] => 15797335
[patent_doc_number] => 20200121810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => High-Intensity Focused Ultrasound-Induced Mechanochemical Transduction in Synthetic Elastomers
[patent_app_type] => utility
[patent_app_number] => 16/654569
[patent_app_country] => US
[patent_app_date] => 2019-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16654569
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/654569 | High-intensity focused ultrasound-induced mechanochemical transduction in synthetic elastomers | Oct 15, 2019 | Issued |
Array
(
[id] => 17821548
[patent_doc_number] => 11426472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis
[patent_app_type] => utility
[patent_app_number] => 17/285717
[patent_app_country] => US
[patent_app_date] => 2019-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 6464
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285717
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285717 | Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis | Oct 14, 2019 | Issued |
Array
(
[id] => 15765991
[patent_doc_number] => 20200114013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => Boron Enriched Linker ("BEL") compositions for boron neutron capture therapy and methods thereof
[patent_app_type] => utility
[patent_app_number] => 16/602468
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16602468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/602468 | Boron enriched linker ("BEL") compositions for boron neutron capture therapy and methods thereof | Oct 9, 2019 | Issued |